Projects per year
Fingerprint Dive into the research topics where Mark Garzotto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Androgens
Medicine & Life Sciences
Prostate-Specific Antigen
Medicine & Life Sciences
Prostate
Medicine & Life Sciences
Prostatectomy
Medicine & Life Sciences
Calcitriol
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2002 2018
- 1 Finished
PACIFIC NORTHWEST PROSTATE CANCER SPORE
Garzotto, M., Alumkal, J., Higano, C., Hood, L., Lange, P., Plymate, S., Mostaghel, E., Vessella, R. L., Etzioni, R., Gleave, M., Yu, E. Y. -., Stanford, J., Nelson, P. & Etzioni, R.
9/19/02 → 8/31/18
Project: Research project
Androgen Receptors
Prostate
Prostatic Neoplasms
Radiation Effects
Radiation
Research Output 1995 2019
7
Citations
(Scopus)
Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: The randomized phase III NRG Oncology RTOG 0521 Trial
Rosenthal, S. A., Hu, C., Sartor, O., Gomella, L. G., Amin, M. B., Purdy, J., Michalski, J. M., Garzotto, M., Pervez, N., Balogh, A. G., Rodrigues, G. B., Souhami, L., Reaume, M. N., Williams, S. G., Hannan, R., Horwitz, E. M., Raben, A., Peters, C. A., Feng, F. Y., Shipley, W. U. & 1 others, , Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1159-1168 10 p.Research output: Contribution to journal › Article
docetaxel
Androgens
Prostatic Neoplasms
Radiotherapy
Drug Therapy
Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes
Chakiryan, N., Martinez, A., Gao, L., Liu, J-J., Amling, C., Garzotto, M. & Kopp, R., Jul 1 2019, In : The Journal of urology. 202, 1, p. 76-82 7 p.Research output: Contribution to journal › Article
Lymph Nodes
Carcinoma
Drug Therapy
Survival
Adjuvant Chemotherapy
Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial
Zhang, Z., Garzotto, M., Davis, E. W., Mori, M. T., Stoller, W. A., Farris, P. E., Wong, C. P., Beaver, L. M., Thomas, G., Williams, D. E., Dashwood, R. H., Hendrix, D. A., Ho, E. & Shannon, J. J., Jan 1 2019, In : Nutrition and Cancer.Research output: Contribution to journal › Article
Brassica
Biological Availability
Prostate
Randomized Controlled Trials
Histone Deacetylases
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomy
Chakiryan, N. H., Acevedo, A. M., Conlin, M., Garzotto, M., Chen, Y., Liu, J. J., Amling, C. & Kopp, R., Jan 1 2019, In : Urologic Oncology: Seminars and Original Investigations.Research output: Contribution to journal › Article
Prostatectomy
Lymph Node Excision
Lymph Nodes
Logistic Models
Proportional Hazards Models
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421
Lara, P. N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N. J., Hussain, M., Twardowski, P. W., Garzotto, M., Monk, J. P., Carducci, M., Goldkorn, A., Mack, P. C., Thompson, I., Van Loan, M. & Quinn, D. I., Jan 1 2018, In : Cancer Treatment and Research Communications. 16, p. 18-23 6 p.Research output: Contribution to journal › Article
bis(2,3,3,3-tetrachloropropyl) ether
Bone Remodeling
Castration
Prostatic Neoplasms
Biomarkers